JUPITER-06

NCT03829969 📎

Regimen

Experimental: toripalimab + paclitaxel/cisplatin (TP)
Control: placebo + paclitaxel/cisplatin (TP)

Population

Treatment-naive advanced ESCC

Key finding

mPFS HR 0.58 (95% CI 0.46-0.74, p<0.0001); OS HR 0.58 (95% CI 0.43-0.78, p=0.0004); both primary endpoints met at interim

Source: PMID 35245446

Timeline